Asco conference 2018

ASCO offers premier scientific events for oncology professionals, patient advocates, industry representatives, and major media outlets worldwide. Best of ASCO Washington DC. Precision medicine has led to many advances in cancer care, but there is still much to learn in this growing field of research. The meeting will bring together more than 30oncology professionals to.

What is ASCO Oncology Practice conference? When is ASCO Symposium? ASCO Daily News is the official conference reporter for ASCO meetings and symposia, providing high-quality, unbiased research summaries and oncology news to members and oncology health care providers. Johnson, M FASCO, Daniel F. McCormick Place, Chicago, United States of America.

Unless you plan to attend the meeting in person, you do NOT need to register through Media Headquarters. ASCO is waiving ASCOVirtual registration fees for ASCO Members! ASCO Members must still register for the meeting through the registration website, but will not be charged.

Here are key takeaways from the meeting. Dr Joseph Sparano spoke with. CSCO Annual Meeting from Sept. Japanese Society of Medical Oncology Annual Meeting.

The 22th Annual Meeting of Chinese Society of Clinical Oncology Agenda. Fizazi and colleagues presented longer term efficacy and safety analyses from the phase III LATITUDE trial. Chicago, IL (UroToday.com) Currently the standard of care treatment for patients with metastatic renal cell carcinoma (MRCC), after being treated with immune checkpoint inhibitors (CPI) therapy, includes VEGF receptor Tyrosine Kinase Inhibitors (TKIs).

Poster accepted as online publication at the American Society of Clinical Oncology Conference. Non-Small Cell Lung Cancer. Shah-Manek B, Karki C, Whitmire S, Ha L, Martino S, Wriede V, Levent A. Weichselbaum, MD gave an interesting overview of oligometastatic disease in different cancers. All ESMO members are able to access the Congress webcast via OncologyPRO.

It will also be available online for the first months following the Congress to all delegates who elect to pay the additional webcast fee. ASCO Annual Meeting Maintenance Therapy for Metastatic Colorectal Cancer: Benefit Seen With Panitumumab Combination. Although the optimal. The addition of the EGFR inhibitor nimotuzumab to a chemoradiotherapy (CRT) regimen using cisplatin improved progression-free survival (PFS) and disease-free survival (DFS) in patients with locally advanced squamous cell carcinoma of the. Moxetumomab pasudotox produced deep and.

Spratt, M of the University of Michigan, discusses a large-scale gene-expression analysis and meta-analysis of RTOG trials on androgen receptor activity and radiotherapeutic sensitivity in. CancerCare is a national nonprofit organization providing free, professional support services for anyone affected by cancer. Category: Science blog.

Around 40cancer experts descended on Chicago to share a glimpse of the latest in cancer prevention, diagnosis and treatment. ASCO : Mobile and Sensor Technology May Lead to Reduced Symptom Severity in Patients With Head and Neck Cancer A randomized clinical trial evaluating the use of mobile and sensor technology to remotely monitor symptoms in patients receiving radiation therapy for head and neck cancer found that use of this tech. The American Society for Clinical Oncology (ASCO) Annual Meeting is the largest of its kind in the world. ASCO : KEYNOTE-4Trial Evaluates Immunotherapy in Advanced Clear Cell Renal Cell Carcinoma Interim from cohort A of KEYNOTE-42 a phase II trial evaluating pembrolizumab (Keytruda) as first-line treatment for advanced clear cell renal cell carcinoma (RCC), were presented by McDermo.

Where avai lable, links to the meeting program, abstract titles, or online abstracts are provided below each listing. ASCO would like to thank its committees for their volunteer efforts. The 2nd European CAR T-Cell Meeting was held in Spain and organized jointly by the European Hematology Association (EHA) and the European Society for Blood and Marrow Transplantation (EMBT).

ESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe.